Sugi Predict

Sugi Predict / Compounds / SCHEMBL4007176

SCHEMBL4007176

SCHEMBL4007176

CCCCCCCCCCCCCCCCOC[C@@H](COP(=O)(O)OCCCCCC[N+](C)(C)C)OC(C)=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA1D P25100 1/20 0.69
▸ PTAFR P25105 1/20 0.69
▸ HTR1D P28221 1/20 0.69
▸ HTR2C P28335 1/20 0.69
▸ ADRA1B P35368 1/20 0.69
▸ DRD3 P35462 1/20 0.69
▸ TMEM97 Q5BJF2 1/20 0.69
▸ FABP3 P05413 1/20 0.58
▸ PLA2G2C Q5R387 1/20 0.53
▸ MAPT P10636 1/20 0.53
▸ RECQL P46063 1/20 0.51
▸ PRKD3 O94806 1/20 0.50
▸ PRKCG P05129 1/20 0.50
▸ PRKCB P05771 1/20 0.50
▸ PRKCA P17252 1/20 0.50
▸ PRKCH P24723 1/20 0.50
▸ AKT1 P31749 1/20 0.50
▸ PRKCI P41743 1/20 0.50
▸ PRKCE Q02156 1/20 0.50
▸ PRKCQ Q04759 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2290669 1.00 ADRA1D (0.69) ADRA1DPTAFRHTR1DHTR2CADRA1B
SCHEMBL2541438 0.94 ADRA1D (0.77) ADRA1DPTAFRHTR1DHTR2CADRA1B
SCHEMBL26642985 0.94 ADRA1D (0.77) ADRA1DPTAFRHTR1DHTR2CADRA1B
SCHEMBL26642897 0.94 ADRA1D (0.77) ADRA1DPTAFRHTR1DHTR2CADRA1B
SCHEMBL23521232 0.94 ADRA1D (0.77) ADRA1DPTAFRHTR1DHTR2CADRA1B
SCHEMBL23521233 0.94 ADRA1D (0.77) ADRA1DPTAFRHTR1DHTR2CADRA1B
Platelet Activating Factor SCHEMBL14523316 0.94 ADRA1D (0.77) ADRA1DPTAFRHTR1DHTR2CADRA1B
Platelet Activating Factor SCHEMBL12235513 0.94 ADRA1D (0.77) ADRA1DPTAFRHTR1DHTR2CADRA1B
Platelet Activating Factor SCHEMBL2546758 0.94 ADRA1D (0.77) ADRA1DPTAFRHTR1DHTR2CADRA1B
SCHEMBL26642894 0.94 ADRA1D (0.77) ADRA1DPTAFRHTR1DHTR2CADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003082199-A2 PLATELET-ACTIVATING FACTOR ANTAGONISTS AS ANALGESIC, ANTI-INFLAMMATORY, UTERINE CONTRACTION INHIBITING, AND ANTI-TUMOR AGENTS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2003-10-09 — — WO claimed
WO-2009080033-A1 COMPRESSED CHEWING GUM COMPRISING METFORMIN FERTIN PHARMA A/S (DK) 2009-07-02 — — WO disclosed
WO-2009080025-A1 COMPRESSED CHEWING GUM COMPRISING METFORMIN FERTIN PHARMA A/S (DK) 2009-07-02 — — WO disclosed
WO-2003082199-A2 PLATELET-ACTIVATING FACTOR ANTAGONISTS AS ANALGESIC, ANTI-INFLAMMATORY, UTERINE CONTRACTION INHIBITING, AND ANTI-TUMOR AGENTS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2003-10-09 — — WO disclosed
EP-0707489-A4 ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF SCOTGEN BIOPHARMACEUTICALS INC (US) 1998-07-29 — — EP disclosed
EP-0707489-A1 ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF Scotgen Biopharmaceuticals, Inc. (US) 1996-04-24 — — EP disclosed
EP-0625911-A1 MALARIA TREATMENTS. UNIV LONDON (GB) 1994-11-30 — — EP disclosed
WO-1994025053-A1 ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF SCOTGEN BIOPHARMACEUTICALS, INC. (US) 1994-11-10 — — WO disclosed
WO-1994012667-A1 INHIBITORS OF ARACHIDONIC ACID METABOLITES FOR PREVENTING NEUROLOGICAL DAMAGE THE UNITED STATES DEPARTMENT OF THE ARMY (US) 1994-06-09 — — WO disclosed
WO-1993015761-A1 MALARIA TREATMENTS UNIVERSITY COLLEGE LONDON (GB) 1993-08-19 — — WO disclosed